Features | Partner Sites | Information | LinkXpress
Sign In
ElsMed
Agfa Healthcare
Ampronix

MR-Guided, Focused Ultrasound Treatment Stops Essential Tremors

By Medimaging International staff writers
Posted on 24 Mar 2011
Magnetic resonance (MR)-guided focused ultrasound was used to successfully treat a patient with essential tremor (ET), a progressive neurologic disorder that affects millions of people worldwide and causes involuntary shaking of the hands, head, face, eyelids, voice, or other muscles.

The procedure has been life changing for the patient, according to W. Jeffrey Elias, MD, a neurosurgeon from the University of Virginia (UVA; Charlottesville, USA) and a leading authority on the treatment of movement disorders. "He had been unable to use his dominant right hand for over a decade because it shook uncontrollably. When we completed the treatment, his tremor was gone. In the recovery room, he used his right hand to drink from a cup without spilling, and he even worked on a crossword puzzle."

Performed on February 25, 2011, the treatment marked the start of a first in the world clinical trial being funded by the Focused Ultrasound Surgery Foundation. The single-arm, nonrandomized pilot study is being conducted at UVA and is expected to treat as many as 15 patients with ET under a US Food and Drug Administration (FDA)-approved protocol. Dr. Elias is the lead investigator.

During the MR-guided focused ultrasound procedure, pulses of focused ultrasound waves were directed through the patient's scalp and skull to a precisely targeted spot in the thalamus--a region deep within the brain known to be an effective target for treating ET and other movement disorders. The patient received no anesthesia for the treatment and was able to provide feedback to Dr. Elias and his team after each sonication. Following the treatment, he walked out of the focused ultrasound suite reporting that the ultrasound treatments were painless.

Per study protocol, the patient remained in the hospital overnight and returned home the next day. A follow-up visit a week later indicated that his right hand was functioning normally. Additional follow-up evaluations will occur 30 and 90 days post treatment, and Dr. Elias is hopeful that the patient's tremor will not return. While excited about the remarkable outcome this first treatment, Dr. Elias cautioned that it is only the initial step in a lengthy process. "We need to complete this study and other clinical trials successfully before this treatment is eligible for approval by the FDA and its counterparts in other countries," he noted.

Chairman of the Focused Ultrasound Surgery Foundation (Charlottesville, VA, USA), Neal Kassell, MD, noted that the success of this study could lead to other new treatments. "By demonstrating that MR-guided focused ultrasound can safely and effectively treat tissue deep in the brain with great precision and accuracy, we will open the door for treating a variety of conditions such as Parkinson's disease, brain tumors, and epilepsy. Much work remains to be done, but the path is clear. Because the brain poses more complex technical challenges than other organs, success in treating ET could advance the entire field of MR-guided focused ultrasound. This study will undoubtedly inspire researchers who are developing new focused ultrasound therapies for the liver, breast and prostate, which are less complicated to treat."

To further clinical research for ET, the Foundation is funding a second pilot study at Sunnybrook Health Sciences Center (Toronto, Canada). That clinical trial is scheduled to begin later in 2011 under a Health Canada-approved protocol.

Current treatment options for ET range from medication to surgery. In the United States, medication therapy provides satisfactory symptom control for many of the 10 million people with ET. For patients who do not respond to medication, the surgical procedures of choice are stereotactic thalamotomy or deep brain stimulation of the ventralis intermedius nucleus of the thalamus.

The UVA study is the first step in determining if MR-guided focused ultrasound is a safe and effective treatment for ET and if it offers benefits beyond current surgical options. The study is enrolling patients who are 18 to 80 years old and have completed trials of at least two ET tremor medications without success. Before and three months after treatment, participating patients are being evaluated for general health, neurologic status, and tremor measurements. The study is also collecting information about any device/procedure-related side effects that occur during the follow-up period.

During treatment, patients remain awake and do not receive anesthesia. They are positioned on the ExAblate Neuro, a system manufactured by InSightec, Ltd. (Haifa, Israel) that has a customized table with a helmet-like head unit containing phased array focused ultrasound transducers. The table is placed inside a high-resolution MR scanner that provides imaging for precise targeting. The scanner also provides thermal feedback to confirm and control sonication temperatures. Treatments are completely noninvasive and do not involve ionizing radiation.

All study treatments are being performed at the UVA Focused Ultrasound Center, which was established under a partnership of UVA, the Commonwealth of Virginia, InSightec, and the Focused Ultrasound Surgery Foundation.

Related Links:

University of Virginia
InSightec



Channels

Radiography

view channel
Image: Bar graph shows the change in detection method over time (1990-2011) for breast cancer cases in patients aged 75 years and older (n = 1162). Pt/PhysD = detection by patient or physician (Photo courtesy of the Radiological Society of North America).

Mammography Screening Helpful for Women Over 75

Mammography-identified breast cancer is associated with a change to earlier-stage diagnosis in older women, which was shown to result in reducing the rate of more advanced, hard-to-treat cases, according... Read more

MRI

view channel
Image: The levels of activity in different parts of the spinal cord of resting individuals were measured using fMRI (Photo courtesy of Barry RL, Smith SA, Dula AN, et al, eLIfe journal, August 5, 2014).

Ultrahigh-Field fMRI Findings May Help Patients Recover from Spinal Cord Injury

Researchers have achieved the first validated noninvasive measurement of neural signaling in the spinal cords of healthy human volunteers. Their imaging technology may aid efforts to help patients recover... Read more

Nuclear medicine

view channel

PET/CT Using FDG-Labeled Leukocytes Detects Infection in Acute Pancreatitis Patients

A study out of India that identifies infection in patients with pancreatic fluid collections may rapidly and effectively rule out active infection in the body. This treatment may help in making nuclear medicine imaging a mainstay in clinical management practices. Acute pancreatitis (AP) is an abrupt inflammation of the pancreas.... Read more

General/Advanced Imaging

view channel

Diagnostic Imaging Tests Ordered by General Practitioners in Australia Nearly Double in 10 Years

A 45% increase in diagnostic imaging tests ordered by Australian general practitioners (GPs) is being fueled by increasing GP visits, an escalating number of problems managed at doctor visits, and a higher probability that GPs order imaging tests for these problems, according to a new study. Based on a long-term national... Read more

Imaging IT

view channel
Image: An X-ray using the ClearRead bone suppression software technology (Photo courtesy of Riverain Technologies).

Bone Suppression Software Used to Optimize Diagnostic Capability of X-Ray Systems

Clinicians are gathering important information from the most routine imaging exam, the chest X-ray, by using advanced software that enhances X-ray images captured by the equipment they already have or... Read more

Industry News

view channel

Acquisition Includes Radiation Simulation Software for Radiotherapy Applications

Varian Medical Systems, Inc. (Palo Alto, CA, USA) has acquired certain assets of Transpire, Inc. (Gig Harbor, WA, USA) including the Acuros dose calculation software, which has been incorporated into Varian’s BrachyVision and Eclipse treatment planning software systems. The acquisition closed at the end of July 2014.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.